BIOMAT Database Logo BIOMAT Database Logo

Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE) Caused by Etoricoxib. 2016

M E Caralli, and M Seoane Rodríguez, and P Rojas Pérez-Ezquerra, and R Pelta Fernández, and M De Barrio Fernández
Allergy Department. Hospital General Universitario Gregorio Marañón, Madrid, Spain.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010003 Osteoarthritis A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans. Arthritis, Degenerative,Osteoarthrosis,Osteoarthrosis Deformans,Arthroses,Arthrosis,Arthritides, Degenerative,Degenerative Arthritides,Degenerative Arthritis,Osteoarthritides,Osteoarthroses
D010328 Patch Tests Skin tests in which the sensitizer is applied to a patch of cotton cloth or gauze held in place for approximately 48-72 hours. It is used for the elicitation of a contact hypersensitivity reaction. Patch Testing,Patch Test,Patch Testings,Test, Patch,Testing, Patch,Testings, Patch,Tests, Patch
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D003875 Drug Eruptions Adverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions. Dermatitis Medicamentosa,Dermatitis, Adverse Drug Reaction,Maculopapular Drug Eruption,Maculopapular Exanthem,Morbilliform Drug Reaction,Morbilliform Exanthem,Drug Eruption,Drug Eruption, Maculopapular,Drug Eruptions, Maculopapular,Drug Reaction, Morbilliform,Drug Reactions, Morbilliform,Eruption, Drug,Eruption, Maculopapular Drug,Eruptions, Drug,Eruptions, Maculopapular Drug,Exanthem, Maculopapular,Exanthem, Morbilliform,Exanthems, Maculopapular,Exanthems, Morbilliform,Maculopapular Drug Eruptions,Maculopapular Exanthems,Morbilliform Drug Reactions,Morbilliform Exanthems,Reaction, Morbilliform Drug,Reactions, Morbilliform Drug
D005076 Exanthema Diseases in which skin eruptions or rashes are a prominent manifestation. Classically, six such diseases were described with similar rashes; they were numbered in the order in which they were reported. Only the fourth (Duke's disease), fifth (ERYTHEMA INFECTIOSUM), and sixth (EXANTHEMA SUBITUM) numeric designations survive as occasional synonyms in current terminology. Rash,Skin Rash,Exanthem,Rash, Skin
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077613 Etoricoxib A sulfone and pyridine derivative that acts as a cyclooxygenase-2 inhibitor. It is used as a NSAID for the treatment of pain associated with RHEUMATOID ARTHRITIS and ANKYLOSING SPONDYLITIS. It is also used for the short-term treatment of moderate postoperative dental pain. Arcoxia,L-791456,MK 0663,MK-0663,L 791456,L791456,MK0663
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents

Related Publications

M E Caralli, and M Seoane Rodríguez, and P Rojas Pérez-Ezquerra, and R Pelta Fernández, and M De Barrio Fernández
Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by golimumab.
May 2017, International journal of dermatology,
M E Caralli, and M Seoane Rodríguez, and P Rojas Pérez-Ezquerra, and R Pelta Fernández, and M De Barrio Fernández
Everolimus-Induced Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE).
January 2016, Dermatitis : contact, atopic, occupational, drug,
M E Caralli, and M Seoane Rodríguez, and P Rojas Pérez-Ezquerra, and R Pelta Fernández, and M De Barrio Fernández
Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by oral metronidazole.
December 2014, Cutaneous and ocular toxicology,
M E Caralli, and M Seoane Rodríguez, and P Rojas Pérez-Ezquerra, and R Pelta Fernández, and M De Barrio Fernández
Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by mefenamic acid.
January 2019, JAAD case reports,
M E Caralli, and M Seoane Rodríguez, and P Rojas Pérez-Ezquerra, and R Pelta Fernández, and M De Barrio Fernández
Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by telmisartan-hydrochlorothiazide.
December 2010, Cutaneous and ocular toxicology,
M E Caralli, and M Seoane Rodríguez, and P Rojas Pérez-Ezquerra, and R Pelta Fernández, and M De Barrio Fernández
Zoledronic acid-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE).
September 2021, BMJ case reports,
M E Caralli, and M Seoane Rodríguez, and P Rojas Pérez-Ezquerra, and R Pelta Fernández, and M De Barrio Fernández
Pustulobullous variant of SDRIFE (symmetrical drug-related intertriginous and flexural exanthema).
June 2017, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG,
M E Caralli, and M Seoane Rodríguez, and P Rojas Pérez-Ezquerra, and R Pelta Fernández, and M De Barrio Fernández
Pustulobullöse Variante eines SDRIFE (symmetrical drug-related intertriginous and flexural exanthema).
June 2017, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG,
M E Caralli, and M Seoane Rodríguez, and P Rojas Pérez-Ezquerra, and R Pelta Fernández, and M De Barrio Fernández
Systemic drug-related intertriginous and flexural exanthema (SDRIFE).
August 2009, Dermatology online journal,
M E Caralli, and M Seoane Rodríguez, and P Rojas Pérez-Ezquerra, and R Pelta Fernández, and M De Barrio Fernández
Symmetrical drug-related intertriginous and flexural exanthema caused by celecoxib.
January 2014, International journal of dermatology,
Copied contents to your clipboard!